Free Trial
OTCMKTS:HKMPF

Hikma Pharmaceuticals (HKMPF) Stock Price, News & Analysis

Hikma Pharmaceuticals logo
$26.93 0.00 (0.00%)
As of 05/9/2025

About Hikma Pharmaceuticals Stock (OTCMKTS:HKMPF)

Key Stats

Today's Range
$26.93
$26.93
50-Day Range
$25.80
$27.51
52-Week Range
$22.33
$28.92
Volume
N/A
Average Volume
1,873 shs
Market Capitalization
$5.98 billion
P/E Ratio
N/A
Dividend Yield
3.56%
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Receive HKMPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

HKMPF Stock News Headlines

Elon Warns “America Is Broke”. Trump’s Plan Inside.
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...
See More Headlines

HKMPF Stock Analysis - Frequently Asked Questions

Hikma Pharmaceuticals' stock was trading at $24.12 on January 1st, 2025. Since then, HKMPF shares have increased by 11.7% and is now trading at $26.9313.
View the best growth stocks for 2025 here
.

Shares of HKMPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Record date for 5/1 Dividend
3/21/2025
Ex-Dividend for 5/1 Dividend
3/21/2025
Dividend Payable
5/01/2025
Today
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:HKMPF
Previous Symbol
OTC:HKMPF
CIK
N/A
Employees
9,100
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.88 billion
Cash Flow
$3.18 per share
Price / Cash Flow
8.46
Book Value
$10.03 per share
Price / Book
2.69

Miscellaneous

Free Float
N/A
Market Cap
$5.98 billion
Optionable
Not Optionable
Beta
0.57

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:HKMPF) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners